Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study
JMIR Research Protocols · 2025
DOI: 10.2196/63339 ↗Kurz gefasst
Leitlinie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Zijun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University,…. Hauptthemen laut MEDLINE: Multimorbidity, Decision Support Systems, Clinical, Practice Guidelines as Topic. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The burden of multimorbidity is increasing globally, which complicates the use of guidelines in clinical practice and health care: practitioners may need to increasingly refer to multiple guidelines with potentially conflicting recommendations.
Objective
We aim to develop a guideline-based decision support framework for the management of patients with multimorbidity to help clinicians efficiently evaluate, select, and adapt recommendations focusing on the different comorbidities and aspects of multimorbidity.
Methods
We will conduct the project using the following steps: (1) needs assessment (searching published literature and documents on guideline use in multimorbidity care through the study initiators, and assessing the necessity of developing a comprehensive decision-making framework focusing on multimorbidity in a broad sense), (2) establishing international working groups (a coordination team, an evidence support group, and a consensus group) by leveraging existing participants’ networks and inviting experts with relevant academic publications or activities, (3) conducting literature reviews of multimorbidity guidelines and original qualitative research involving interest-holders in multimorbidity care and/or guideline development to formulate an initial draft framework, (4) a consensus process including an expert survey and a consensus meeting, (5) formulating and releasing the final framework, and (6) testing the framework (collecting feedback through educating health professionals in different settings and applying the framework in practice to evaluate and improve it). We plan to complete the project within 3 years.
Results
The project has started in March 2024 and is due to conclude in June 2026. As of May 2025, we have finished the literature reviews and qualitative studies and are currently conducting the first round of the expert survey.
Conclusions
This framework will help clinicians from all levels of health care institutions to make decisions in the management of patients with multimorbidity based on the latest available evidence, and to reduce potential health risks to their patients. One limitation of this framework is that such a broad framework may not fully fit all disease combinations or realistic situations. To reduce the degree of inapplicability, after completion of the framework, we will continue to monitor its use with regular updates as needed. International Registered Report Identifier (IRRID) DERR1-10.2196/63339
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
- Key Laboratory of Evidence Based Medicine of Gansu Province, Lanzhou, China.
- Institute of Health Data Science, Lanzhou University, Lanzhou, China.
- Institute of Global Health, University of Geneva, Geneva, Switzerland.
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- School of Public Health, Lanzhou University, Lanzhou, China.
ORCID-Profile: Zijun Wang, Ling Wang, Bingyi Wang, Hongfeng He, Zhewei Li, Di Zhu, Jie Zhang, Huayu Zhang, Yaolong Chen, Janne Estill
Zitieren
APA
Wang, Z., Wang, L., Wang, B., He, H., Li, Z., Zhu, D., Zhang, J., Zhang, H., Chen, Y., & Estill, J. (2025). Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study. JMIR Research Protocols. https://doi.org/10.2196/63339
Vancouver
Wang Z, Wang L, Wang B, He H, Li Z, Zhu D, et al. Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study. JMIR Research Protocols. 2025. doi:10.2196/63339
BibTeX
@article{Wang2025,
author = {Wang, Zijun and Wang, Ling and Wang, Bingyi and He, Hongfeng and Li, Zhewei and Zhu, Di and Zhang, Jie and Zhang, Huayu and Chen, Yaolong and Estill, Janne},
title = {Guideline-Based Clinical Decision Support Framework for Multimorbidity: Protocol for a Formulation and Testing Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/63339}
}
EUVIMED